Janney Montgomery Scott LLC Buys New Holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Janney Montgomery Scott LLC purchased a new position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) in the third quarter, Holdings Channel reports. The fund purchased 46,535 shares of the company’s stock, valued at approximately $4,367,000.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in GEHC. Pathway Financial Advisers LLC acquired a new position in GE HealthCare Technologies in the first quarter valued at approximately $25,000. Fred Alger Management LLC acquired a new position in shares of GE HealthCare Technologies in the 2nd quarter valued at $26,000. Elkhorn Partners Limited Partnership acquired a new position in shares of GE HealthCare Technologies in the 2nd quarter valued at $31,000. ORG Partners LLC grew its position in shares of GE HealthCare Technologies by 2,475.0% in the 2nd quarter. ORG Partners LLC now owns 412 shares of the company’s stock valued at $32,000 after buying an additional 396 shares during the last quarter. Finally, M&R Capital Management Inc. acquired a new stake in GE HealthCare Technologies during the 3rd quarter worth $33,000. Institutional investors and hedge funds own 82.06% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on the company. Redburn Atlantic raised GE HealthCare Technologies to a “strong-buy” rating in a report on Thursday, August 1st. Wells Fargo & Company increased their price target on shares of GE HealthCare Technologies from $95.00 to $96.00 and gave the stock an “overweight” rating in a research note on Thursday, October 31st. Stifel Nicolaus lifted their price objective on shares of GE HealthCare Technologies from $100.00 to $102.00 and gave the company a “buy” rating in a research note on Monday, September 30th. BTIG Research upgraded shares of GE HealthCare Technologies from a “neutral” rating to a “buy” rating and set a $100.00 target price for the company in a research note on Wednesday, September 18th. Finally, Evercore ISI boosted their price target on GE HealthCare Technologies from $98.00 to $102.00 and gave the company an “outperform” rating in a research report on Tuesday, October 1st. One investment analyst has rated the stock with a sell rating, five have issued a hold rating, eight have issued a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, GE HealthCare Technologies has a consensus rating of “Moderate Buy” and an average target price of $94.36.

Insider Activity at GE HealthCare Technologies

In other GE HealthCare Technologies news, CEO Roland Rott sold 3,577 shares of the stock in a transaction on Wednesday, November 6th. The stock was sold at an average price of $86.48, for a total transaction of $309,338.96. Following the transaction, the chief executive officer now owns 24,298 shares in the company, valued at $2,101,291.04. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.27% of the stock is owned by company insiders.

GE HealthCare Technologies Stock Down 2.7 %

Shares of NASDAQ:GEHC opened at $85.94 on Friday. The company has a 50 day moving average of $88.90 and a 200-day moving average of $83.51. GE HealthCare Technologies Inc. has a one year low of $66.39 and a one year high of $94.55. The stock has a market cap of $39.26 billion, a price-to-earnings ratio of 23.61, a P/E/G ratio of 3.11 and a beta of 1.24. The company has a debt-to-equity ratio of 1.12, a current ratio of 1.23 and a quick ratio of 0.98.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its earnings results on Wednesday, October 30th. The company reported $1.14 EPS for the quarter, topping the consensus estimate of $1.06 by $0.08. The firm had revenue of $4.86 billion for the quarter, compared to the consensus estimate of $4.87 billion. GE HealthCare Technologies had a net margin of 8.56% and a return on equity of 25.19%. The business’s quarterly revenue was up .9% on a year-over-year basis. During the same period last year, the company posted $0.99 EPS. On average, sell-side analysts forecast that GE HealthCare Technologies Inc. will post 4.29 earnings per share for the current year.

GE HealthCare Technologies Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Friday, October 18th will be issued a dividend of $0.03 per share. This represents a $0.12 dividend on an annualized basis and a dividend yield of 0.14%. The ex-dividend date of this dividend is Friday, October 18th. GE HealthCare Technologies’s payout ratio is presently 3.30%.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.